Deflate Hype About New Auvelity for Depression

December 2022

You’ll hear buzz about new Rx Auvelity for depression...an ER combo of dextromethorphan 45 mg and bupropion 105 mg given bid.

You might expect bupropion to be the primary active ingredient.

But the manufacturer is actually touting dextromethorphan for its antidepressant effects...as an NMDA receptor blocker.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Migraine Put CV Risks With Triptans in Perspective
Cough & Cold Reinforce Nondrug Measures for Cough and Cold Symptoms
Antithrombotics Don’t Delay Restarting Anticoagulation for Atrial Fib After a GI Bleed
Diabetes Evaluate Treatments for Kidney Disease and Diabetes
Antidepressants Deflate Hype About New Auvelity for Depression
Devices Help Patients Navigate OTC Hearing Aids
Lice Comb Through Head Lice Treatments
Psoriasis Demystify Systemic Meds for Psoriasis
Education and Training Be Ready to Manage Challenges With Learners